Date published: 2026-6-5

1-800-457-3801

SCBT Portrait Logo
Seach Input

UNKL Inhibitors

UNKL inhibitors are a class of chemical compounds that target and inhibit the activity of the protein encoded by the unkempt-like (UNKL) gene. UNKL is a ubiquitin ligase, a member of the large family of E3 ligases that play a critical role in the ubiquitin-proteasome system, a pathway essential for the regulation of protein degradation in eukaryotic cells. By catalyzing the transfer of ubiquitin molecules to specific substrates, UNKL is involved in the post-translational modification of proteins, marking them for degradation by the proteasome. The regulation of protein turnover through ubiquitination is vital for numerous cellular processes, including cell cycle regulation, signal transduction, and the maintenance of protein homeostasis. Dysregulation of ubiquitin ligases such as UNKL can result in abnormal protein accumulation or degradation, which can have profound effects on cellular function. UNKL inhibitors are designed to modulate this ligase activity, reducing or halting its ubiquitination of specific substrates.

Chemically, UNKL inhibitors may vary in structure, but they typically share characteristics that allow them to bind with high specificity to the UNKL protein, blocking its interaction with target substrates or its ability to facilitate the transfer of ubiquitin. These inhibitors are often designed through structure-based drug design, utilizing insights from the three-dimensional structure of UNKL and its active site. Once bound, these compounds can prevent the ubiquitin ligase activity of UNKL, leading to altered cellular pathways, particularly those involved in protein quality control and degradation. The discovery and synthesis of UNKL inhibitors involve intricate processes of chemical optimization, including improving the affinity of the inhibitors for their target, enhancing selectivity against other E3 ligases, and ensuring chemical stability in various experimental environments. This chemical class represents a significant area of interest in the study of protein regulation and degradation pathways.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

PI3K inhibitor that can decrease AKT phosphorylation, affecting downstream signaling related to protein turnover.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

JNK inhibitor that can alter stress and apoptotic signaling pathways, potentially influencing proteins akin to UNKL.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$64.00
$246.00
136
(2)

MEK inhibitor that can reduce ERK pathway activity, possibly affecting protein synthesis and degradation pathways.

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$60.00
$265.00
$1000.00
163
(3)

Proteasome inhibitor that can increase cellular protein levels by preventing degradation, affecting UNKL-like proteins.

Epoxomicin

134381-21-8sc-201298C
sc-201298
sc-201298A
sc-201298B
50 µg
100 µg
250 µg
500 µg
$137.00
$219.00
$449.00
$506.00
19
(2)

Selective proteasome inhibitor that can lead to accumulation of proteins, potentially affecting those similar to UNKL.

Brefeldin A

20350-15-6sc-200861C
sc-200861
sc-200861A
sc-200861B
1 mg
5 mg
25 mg
100 mg
$31.00
$53.00
$124.00
$374.00
25
(3)

ER-Golgi transport inhibitor that can disrupt protein trafficking, potentially impacting proteins in the same pathway as UNKL.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

mTOR inhibitor that can suppress protein synthesis, potentially affecting proteins regulated in a similar manner to UNKL.

Cyclosporin A

59865-13-3sc-3503
sc-3503-CW
sc-3503A
sc-3503B
sc-3503C
sc-3503D
100 mg
100 mg
500 mg
10 g
25 g
100 g
$63.00
$92.00
$250.00
$485.00
$1035.00
$2141.00
69
(5)

Calcineurin inhibitor that can modulate T-cell activation and protein phosphorylation, affecting UNKL-like pathways.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

PI3K inhibitor that can prevent AKT activation, affecting survival and growth signals connected to UNKL-like proteins.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

MEK inhibitor that can block ERK signaling, potentially impacting the regulation of UNKL-like proteins.